The Clorox Company (NYSE:CLX) Stock Holdings Increased by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC boosted its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 5.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 191,919 shares of the company's stock after purchasing an additional 10,149 shares during the quarter. Los Angeles Capital Management LLC owned approximately 0.16% of Clorox worth $31,266,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Innealta Capital LLC acquired a new stake in Clorox in the 2nd quarter valued at about $30,000. Trifecta Capital Advisors LLC grew its position in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after purchasing an additional 130 shares during the last quarter. First Foundation Advisors purchased a new position in shares of Clorox during the 1st quarter worth approximately $31,000. Family Firm Inc. acquired a new position in shares of Clorox in the second quarter worth $31,000. Finally, Quarry LP lifted its holdings in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company's stock valued at $31,000 after purchasing an additional 114 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.57% of the company's stock.

Clorox Stock Down 0.1 %

Shares of NYSE:CLX traded down $0.11 during midday trading on Monday, hitting $165.05. 863,337 shares of the company's stock traded hands, compared to its average volume of 1,244,902. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $169.09. The company has a market cap of $20.43 billion, a PE ratio of 57.65, a P/E/G ratio of 3.05 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The firm's fifty day moving average price is $162.14 and its two-hundred day moving average price is $146.83.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company's revenue for the quarter was up 27.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.49 earnings per share. On average, equities research analysts anticipate that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were paid a dividend of $1.22 per share. The ex-dividend date of this dividend was Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. Clorox's dividend payout ratio is presently 170.04%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CLX. Evercore ISI decreased their target price on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research report on Monday, October 14th. BNP Paribas upgraded Clorox to a "strong sell" rating in a research note on Friday, September 6th. Jefferies Financial Group raised Clorox from a "hold" rating to a "buy" rating and raised their price target for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. DA Davidson upped their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research note on Monday, November 4th. Finally, TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and increased their price objective for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Clorox presently has a consensus rating of "Hold" and a consensus price target of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.